查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2082030

醫療保健領域人工智慧市場：按組件、技術類型、醫療專科、部署模式、應用和最終用戶分類——2026-2032年全球市場預測

Artificial Intelligence in Medicine Market by Component, Technology Type, Medical Specialty, Deployment Mode, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，醫療領域的人工智慧 (AI) 市場將成長至 753.3 億美元，複合年成長率為 25.20%。

主要市場統計數據
基準年 2025 156.2億美元
預計年份：2026年 193.5億美元
預測年份：2032年 753.3億美元
複合年成長率 (%) 25.20%

人工智慧在醫療領域的應用正從實驗階段邁向臨床應用和營運基礎設施建設。在診斷、醫學影像、臨床決策支援、藥物研發、遠端患者監護、收入週期工作流程和精準醫療等領域，人工智慧正被應用於減少變異性、加快決策速度並擴展有限的臨床能力。

這項徵兆有數據支撐。世界衛生組織（WHO）預測，到2030年，全球整體將出現1000萬醫療保健專業人員的缺口，而美國食品藥物管理局（FDA）已批准超過900種人工智慧/機器學習（AI/ML）醫療設備，其中放射科應用佔比最大。人才短缺、監管進步以及醫療數據量的成長，這些因素共同推動人工智慧在醫療保健領域成為提升效率、擴大醫療服務覆蓋範圍和提高醫療品質的核心驅動力。

醫療保健領域人工智慧的變革

最顯著的變化是從一次性解決方案轉向人工智慧驅動的診療路徑。醫院和生命科學公司不再僅僅將人工智慧作為獨立的診斷工具進行評估，而是將人工智慧模型整合到電子健康記錄、影像系統、實驗室工作流程和病人參與平台中。

人工智慧在醫療領域的累積影響

人工智慧在醫療領域的累積影響體現在三個方面：臨床準確性、營運效率和病患就醫便利性。人工智慧影像技術有助於優先處理急診病例，決策支援系統可以及早發現病情惡化，預測分析則可支援慢性病管理的團體健康介入措施。

醫療保健領域人工智慧的關鍵區域洞察

北美在商業化方面處於主導地位，這得益於其成熟的數位醫療基礎設施、強大的學術醫療中心、高普及率的電子健康記錄以及不斷完善的FDA人工智慧醫療醫療設備核准流程。美國仍然是主要的需求中心，這主要得益於積極的法規核准和醫療服務提供者的快速應用。同時，加拿大正透過公共研究網路、省級數位醫療舉措以及國家層面的負責任醫療數據使用指南，推動人工智慧在醫療保健領域的應用。

全球醫療人工智慧市場關鍵群洞察

七國集團憑藉其先進的研究生態系統、龐大的醫療預算、監管能力和強大的臨床測試基礎設施，為全球醫療人工智慧領域提供了堅實的基礎。隨著人工智慧日益融入醫院網路、影像系統、電子健康記錄和連網醫療設備，北約成員國也正將網路安全措施列入優先事項。

主要國家醫療人工智慧的關鍵趨勢

美國在醫療保健領域的人工智慧方面處於領先地位，這得益於其獲得FDA批准的人工智慧/機器學習醫療設備、先進的醫院創新網路、廣泛的臨床數據基礎設施，以及在放射學、循環系統、病理學和行政自動化等領域積極應用人工智慧。加拿大則透過人工智慧研究叢集和公共資助的數位健康計畫做出貢獻，而墨西哥和巴西則致力於擴大遠距遠端醫療、影像現代化和數位健康服務在其龐大且地理分佈廣泛的人口中的普及程度。

為行業領導者提供的實用建議

產業領導者應優先考慮具有可衡量營運價值和明確臨床責任的應用案例。高價值的切入點包括影像分流、自動化文件記錄、患者病情惡化預測、編碼輔助、藥物發現分析、虛擬護理支援、慢性病風險分層以及人工智慧驅動的遠端患者監護。

調查方法

本執行摘要基於二手研究方法，採用公開檢驗的資訊來源，包括監管資料庫、政府衛生統計數據、多邊衛生組織、同行評審文獻和行業認可的政策框架。主要參考資料包括美國食品藥物管理局（FDA）的人工智慧/機器學習醫療設備清單、世界衛生組織（WHO）醫護人員資料、國家醫療保健支出統計資料、資料保護條例和區域數位健康策略。

結論

人工智慧在醫療領域不再只是一種技術類別，它正成為現代醫療保健策略的重要組成部分。其最大價值在於增強臨床醫生的能力、提高診斷速度、減輕行政負擔、擴大醫療服務覆蓋範圍，並在整個專科醫療系統中實現數據驅動的醫療服務。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：醫療領域的人工智慧市場：按組件分類

  • 服務
    • 諮詢服務
    • 整合部署服務
  • 軟體
    • 應用軟體
    • 系統軟體

第8章：醫療領域的人工智慧市場：按技術類型分類

  • 電腦視覺
  • 機器學習
  • 自然語言處理
  • 機器人

第9章：醫療領域的人工智慧市場：依醫療專科分類

  • 循環系統
  • 皮膚科
  • 胃腸病學
  • 神經病學
  • 婦產科
  • 腫瘤學
  • 眼科
  • 整形外科
  • 小兒科
  • 泌尿系統

第10章：醫療領域的人工智慧市場：以部署方式分類

  • 基於雲端的
  • 現場

第11章：醫療領域的人工智慧市場：按應用領域分類

  • 診斷
    • 醫學影像
    • 病理檢測
  • 藥物發現
  • 治療

第12章：醫療領域的人工智慧市場：依最終用戶分類

  • 醫療服務提供方
    • 診所
    • 醫院
  • 製藥公司
  • 研究機構和學術機構

第13章：醫療領域的人工智慧市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章：醫療領域的人工智慧市場：按類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：醫療領域的人工智慧市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Aidoc Medical Ltd.
  • BenevolentAI Limited
  • Butterfly Network, Inc.
  • CloudMedx Inc.
  • Enlitic, Inc.
  • Epic Systems Corporation
  • Exscientia plc
  • Freenome Holdings, Inc.
  • GE HealthCare Technologies Inc.
  • Google LLC By Alphabet Inc.
  • HeartFlow, Inc.
  • Insilico Medicine, Inc.
  • Intel Corporation
  • Koninklijke Philips NV
  • Medtronic plc
  • Merative
  • Nano-X Imaging Ltd.
  • NVIDIA Corporation
  • Owkin, Inc.
  • PathAI, Inc.
  • Qventus, Inc.
  • Recursion Pharmaceuticals, Inc.
  • Siemens Healthineers AG
  • Tempus Labs, Inc.
  • Veradigm Inc.
  • Viz.ai, Inc.
Product Code: MRR-4330CC794AA4

The Artificial Intelligence in Medicine Market is projected to grow by USD 75.33 billion at a CAGR of 25.20% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 15.62 billion
Estimated Year [2026] USD 19.35 billion
Forecast Year [2032] USD 75.33 billion
CAGR (%) 25.20%

Artificial intelligence in medicine is moving from experimentation to clinical and operational infrastructure. Across diagnostics, medical imaging, clinical decision support, drug discovery, remote patient monitoring, revenue-cycle workflows, and precision medicine, AI is being adopted to reduce variation, accelerate decisions, and extend scarce clinical capacity.

The demand signal is data-backed: the World Health Organization projects a global shortfall of 10 million health workers by 2030, while the U.S. FDA has listed more than 900 AI/ML-enabled medical devices, with radiology representing the largest share. This combination of workforce pressure, regulatory momentum, and expanding medical data volumes is positioning AI in healthcare as a core enabler of productivity, access, and quality improvement.

Transformative Shifts in the AI Medicine Landscape

The most significant shift is the transition from point solutions to AI-enabled care pathways. Hospitals and life sciences organizations are no longer evaluating AI only as a standalone diagnostic tool; they are integrating models into electronic health records, imaging systems, laboratory workflows, and patient engagement platforms.

Generative AI is also reshaping the landscape by automating documentation, summarizing patient histories, supporting prior authorization, and improving medical knowledge retrieval. At the same time, regulatory frameworks such as the EU AI Act and FDA guidance on software as a medical device are pushing developers and healthcare providers toward stronger validation, transparency, monitoring, and risk management.

Cumulative Impact of Artificial Intelligence in Medicine

The cumulative impact of artificial intelligence in medicine is being measured across three dimensions: clinical accuracy, operational efficiency, and patient access. AI-assisted imaging can help prioritize urgent cases, decision support can flag deterioration earlier, and predictive analytics can support population health interventions for chronic disease management.

However, sustainable value depends on governance. Bias, model drift, cybersecurity, patient consent, and explainability remain material concerns. Organizations that combine AI deployment with clinical validation, human oversight, and post-deployment performance monitoring are better positioned to convert innovation into measurable outcomes.

Key Regional Insights for AI in Medicine

North America leads in commercialization, supported by mature digital health infrastructure, strong academic medical centers, high electronic health record penetration, and an expanding FDA pathway for AI-enabled medical devices. The United States remains the primary demand center due to active regulatory clearances and advanced provider adoption, while Canada is advancing AI in health through public research networks, provincial digital health initiatives, and national guidance on responsible health data use.

Europe is shaped by strong public health systems, the European Health Data Space, and the EU AI Act, creating a region where trust, data protection, clinical evidence, and algorithmic accountability are central to adoption. Asia-Pacific is scaling rapidly as China, Japan, South Korea, India, and Australia invest in digital hospitals, population health platforms, AI-assisted diagnostics, national health data infrastructure, and technologies that support aging populations and rural care access.

Latin America is adopting AI to improve access in underserved regions, with Brazil and Mexico serving as important hubs for telehealth, imaging modernization, and digital health expansion. The Middle East is investing through national health transformation programs, particularly in GCC markets, where smart hospitals, health information exchanges, and AI-enabled patient experience initiatives are priorities. Africa is using AI in medicine primarily to address workforce shortages, infectious disease surveillance, maternal health, radiology access gaps, and remote diagnostics in areas with limited specialist availability.

Key Group Insights Across Global AI Health Markets

The G7 countries anchor much of the global AI in medicine landscape through advanced research ecosystems, large healthcare budgets, regulatory capacity, and strong clinical trial infrastructure. NATO members add cybersecurity priorities that are increasingly relevant as AI becomes embedded in hospital networks, imaging systems, electronic health records, and connected medical devices.

The European Union is creating a rules-based model for trustworthy AI, with the AI Act classifying many medical AI systems as high risk and requiring stronger documentation, risk management, human oversight, and post-market monitoring. BRICS countries are important adoption centers because of large patient populations, expanding digital health programs, national AI strategies, and policy ambitions to localize healthcare technology capabilities.

ASEAN is emerging as a high-potential region due to mobile-first healthcare access, hospital digitization, cross-border digital health collaboration, and demand for affordable diagnostics. GCC countries are using sovereign investment, national health strategies, and smart hospital programs to accelerate adoption, particularly in digitally advanced health systems across the Gulf, where AI is being aligned with precision medicine, preventive care, and health system transformation agendas.

Key Country Insights in AI in Medicine

The United States leads AI in medicine through FDA-cleared AI/ML-enabled devices, advanced hospital innovation networks, extensive clinical data infrastructure, and strong adoption in radiology, cardiology, pathology, and administrative automation. Canada contributes through AI research clusters and publicly supported digital health programs, while Mexico and Brazil are expanding telehealth, imaging modernization, and digital health access across large and geographically diverse populations.

In Europe, the United Kingdom emphasizes NHS digital transformation, AI assurance, and controlled real-world testing environments, while Germany combines medtech strength with hospital modernization and digital health reimbursement reforms. France supports health data infrastructure and AI research through national digital health priorities, Italy and Spain are improving AI readiness through public health digitization and regional health data programs, and Russia maintains capabilities in medical imaging, clinical software, and applied health informatics despite geopolitical constraints.

China is scaling AI diagnostics, hospital automation, population health analytics, and digital hospital systems under national healthcare digitization priorities. India's large patient base, digital public infrastructure, and telemedicine adoption create strong conditions for AI-enabled access, while Japan and South Korea are advancing robotics, imaging, clinical decision support, and aging-related care technologies. Australia is progressing through national digital health records, remote care needs, rural health priorities, and strong clinical research capacity.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize use cases with measurable operational value and clear clinical ownership. High-value starting points include imaging triage, documentation automation, patient deterioration prediction, coding support, drug discovery analytics, virtual nursing support, chronic disease risk stratification, and AI-enabled remote patient monitoring.

Organizations should also establish AI governance boards, model validation protocols, data quality standards, cybersecurity controls, clinician feedback loops, and post-deployment monitoring processes. The strongest performers in AI in medicine will be those that prove safety, reduce workflow burden, improve interoperability, and demonstrate quantifiable impact on outcomes, cost, and access.

Research Methodology

This executive summary is developed using a secondary research approach grounded in public, verifiable sources, including regulatory databases, government health statistics, multilateral health organizations, peer-reviewed literature, and recognized industry policy frameworks. Key reference points include the FDA AI/ML-enabled medical device list, WHO workforce data, national health expenditure statistics, data protection regulations, and regional digital health strategies.

Insights were synthesized through trend mapping and qualitative assessment of adoption drivers, regulatory conditions, healthcare infrastructure maturity, clinical implementation evidence, and public investment activity. The methodology emphasizes evidence-based interpretation rather than speculative forecasting, market sizing, or market share analysis.

Conclusion

Artificial intelligence in medicine is becoming a strategic layer of modern healthcare, not merely a technology category. Its strongest value lies in augmenting clinicians, improving diagnostic speed, reducing administrative burden, expanding access, and enabling data-driven care across fragmented health systems.

The next phase of AI in medicine will be defined by clinical validation, regulation, interoperability, cybersecurity, and trust. Organizations that combine responsible AI governance with scalable deployment models will be best positioned to support safer, more efficient, and more equitable healthcare delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Artificial Intelligence in Medicine Market, by Component

  • 7.1. Services
    • 7.1.1. Consulting Services
    • 7.1.2. Integration & Deployment Services
  • 7.2. Software
    • 7.2.1. Applications Software
    • 7.2.2. System Software

8. Artificial Intelligence in Medicine Market, by Technology Type

  • 8.1. Computer Vision
  • 8.2. Machine Learning
  • 8.3. Natural Language Processing
  • 8.4. Robotics

9. Artificial Intelligence in Medicine Market, by Medical Specialty

  • 9.1. Cardiology
  • 9.2. Dermatology
  • 9.3. Gastroenterology
  • 9.4. Neurology
  • 9.5. Obstetrics & Gynecology
  • 9.6. Oncology
  • 9.7. Ophthalmology
  • 9.8. Orthopedics
  • 9.9. Pediatrics
  • 9.10. Urology

10. Artificial Intelligence in Medicine Market, by Deployment Mode

  • 10.1. Cloud-Based
  • 10.2. On-Premise

11. Artificial Intelligence in Medicine Market, by Application

  • 11.1. Diagnostics
    • 11.1.1. Medical Imaging
    • 11.1.2. Pathology Detection
  • 11.2. Drug Discovery
  • 11.3. Treatment

12. Artificial Intelligence in Medicine Market, by End-User

  • 12.1. Healthcare Providers
    • 12.1.1. Clinics
    • 12.1.2. Hospitals
  • 12.2. Pharmaceutical Companies
  • 12.3. Research Institutes & Academic Centers

13. Artificial Intelligence in Medicine Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Artificial Intelligence in Medicine Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Artificial Intelligence in Medicine Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Aidoc Medical Ltd.
  • 17.2. BenevolentAI Limited
  • 17.3. Butterfly Network, Inc.
  • 17.4. CloudMedx Inc.
  • 17.5. Enlitic, Inc.
  • 17.6. Epic Systems Corporation
  • 17.7. Exscientia plc
  • 17.8. Freenome Holdings, Inc.
  • 17.9. GE HealthCare Technologies Inc.
  • 17.10. Google LLC By Alphabet Inc.
  • 17.11. HeartFlow, Inc.
  • 17.12. Insilico Medicine, Inc.
  • 17.13. Intel Corporation
  • 17.14. Koninklijke Philips N.V.
  • 17.15. Medtronic plc
  • 17.16. Merative
  • 17.17. Nano-X Imaging Ltd.
  • 17.18. NVIDIA Corporation
  • 17.19. Owkin, Inc.
  • 17.20. PathAI, Inc.
  • 17.21. Qventus, Inc.
  • 17.22. Recursion Pharmaceuticals, Inc.
  • 17.23. Siemens Healthineers AG
  • 17.24. Tempus Labs, Inc.
  • 17.25. Veradigm Inc.
  • 17.26. Viz.ai, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL SPECIALTY, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL SPECIALTY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CONSULTING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONSULTING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CONSULTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTEGRATION & DEPLOYMENT SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTEGRATION & DEPLOYMENT SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTEGRATION & DEPLOYMENT SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL APPLICATIONS SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL APPLICATIONS SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL APPLICATIONS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SYSTEM SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SYSTEM SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SYSTEM SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL COMPUTER VISION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL COMPUTER VISION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL COMPUTER VISION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MACHINE LEARNING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MACHINE LEARNING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MACHINE LEARNING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NATURAL LANGUAGE PROCESSING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NATURAL LANGUAGE PROCESSING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NATURAL LANGUAGE PROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ROBOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ROBOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CARDIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CARDIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DERMATOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DERMATOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROENTEROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GASTROENTEROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROENTEROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL OBSTETRICS & GYNECOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL OBSTETRICS & GYNECOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL OBSTETRICS & GYNECOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ORTHOPEDICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ORTHOPEDICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ORTHOPEDICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PEDIATRICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PEDIATRICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PEDIATRICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL UROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL UROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL UROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CLOUD-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CLOUD-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CLOUD-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ON-PREMISE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ON-PREMISE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ON-PREMISE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PATHOLOGY DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PATHOLOGY DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PATHOLOGY DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DRUG DISCOVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HEALTHCARE PROVIDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HEALTHCARE PROVIDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HEALTHCARE PROVIDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL RESEARCH INSTITUTES & ACADEMIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL RESEARCH INSTITUTES & ACADEMIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL RESEARCH INSTITUTES & ACADEMIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 183. GCC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. GCC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 185. GCC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 186. GCC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 187. GCC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. GCC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 189. GCC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 190. GCC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. GCC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 192. GCC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 193. GCC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 216. G7 ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 217. G7 ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 218. G7 ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 219. G7 ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 220. G7 ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. G7 ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 222. G7 ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 223. G7 ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. G7 ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 225. G7 ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 226. G7 ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 227. NATO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 228. NATO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 229. NATO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 230. NATO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 231. NATO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. NATO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 233. NATO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 234. NATO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. NATO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 236. NATO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 237. NATO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 238. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 250. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 251. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 252. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 253. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 254. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 256. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 257. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 259. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 260. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 261. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 262. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 263. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 264. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 265. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 267. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 268. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 270. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 271. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 272. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 273. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 274. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 275. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 276. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 278. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 279. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 280. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 281. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 282. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 294. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 295. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 296. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 297. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 298. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 300. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 301. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 302. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 303. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 304. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 305. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 306. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 307. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 308. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 309. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 310. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 311. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 312. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 313. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 314. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 315. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 316. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 317. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 318. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 319. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 320. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 321. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY MEDICAL SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 322. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 323. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 324. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 325. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 326. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 327. ITALY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)